Abstract
INTRODUCTION
Cancer cells ferment glucose to lactate in the presence of oxygen, a phenomenon originally described by Otto Warburg and colleagues in the 1920s and later found to promote tumor growth and malignancy [1] [2] [3] [4] . In addition to fostering glycolysis by end-product removal, cytosolic alkalinization and NAD + recycling, the co-extrusion of lactate and protons causes interstitial acidification, which along lactate itself favors tumor invasiveness and facilitates immune response evasion 5 . Lactate levels were double in cervical tumors with metastatic spread compared with malignancies in patients without metastases 6 . Lactic acid release is also a physiological process, as in exercising skeletal muscle, in active macrophages and in brain astrocytes [7] [8] [9] . The transport of lactate in most mammalian cells is mediated by members of the SLC16A family of H + -coupled monocarboxylate transporters (MCTs) 10 . Malignant tumors overexpress MCT1 (SLC16A1) and/or MCT4 (SLC16A3), the latter being characteristic of metastatic cancer in association with HIF-1α upregulation 11 . Potent small-molecule inhibitors specific for MCT1-2 have been synthetized, one of which is currently undergoing a Phase I clinical trial 12 . However, the development of MCT4-specific drugs is lagging.
MCT4-endowed cells, both healthy and cancerous, are the strongest lactate producers. So it seems puzzling that, at about 30 mM 10, 13, 14 , the K m of MCT4 for lactate is more than one order of magnitude higher than the levels of lactate prevailing in tissues and even within hypoxic tumors 6, 15 . Taken at face value, this means that MCT4 runs at a small fraction of its capacity. In contrast, MCT1 has a K m of 3-5 mM 10 . Kinetic transport parameters are determined by measuring initial rates of uptake at increasing concentrations of radiolabeled substrate. Unfortunately, this is not practical for MCTs in mammalian cells, because uptake is too fast, demanding high levels of radioactivity and sophisticated stop-flow devices. The introduction of pH-sensitive dyes in the 1980s revolutionized the field by permitting MCT activity determinations with high spatiotemporal resolution 16, 17 . With the additional advantage that any substrate could be studied with the same probe, most of what we know about the functionality of the monocarboxylate transporters was learnt from substrate-induced acidification. However, there was a caveat. In order to obtain detectable acidifications, experiments had to be done in the absence of bicarbonate.
Genetically-encoded FRET nanosensors have been recently used by several laboratories to directly monitor lactate and pyruvate dynamics in various cell types, in vitro and in vivo [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . During the characterization of a MCT4-rich cell line with a FRET sensor we detected robust transport at low lactate concentrations. The present manuscript describes a set of experiments prompted by that observation. o C in 95% air/5% CO 2 in DMEM/F12 supplemented with 10% fetal bovine serum. Cultures were transfected at 60% confluence using Lipofectamine 3000 (ThermoFisher) and studied after 24-72 h. To obtain macrophages, blood was collected by venepuncture from ten healthy male volunteers. Age of donors ranged from 25 to 45 years. Ethical guidelines stipulated by the Declaration of Helsinki principles were adhered to. Approval was obtained from the Medical Ethical Committee of the Faculty of Medicine, Universidad Austral de Chile. All donors were informed about the nature of the studies and gave their written consent to participate. Samples were treated anonymously. Monocytes were isolated from whole blood treated with 3.8% sodium citrate, by Percoll TM density gradient centrifugation (GE Healthcare, Sweden). Macrophage differentiation of human monocytes was induced by treatment with 25 nM macrophage colonystimulating factor for seven days. Human monocytes-derived macrophages were treated with 100 ng/mL IFN-γ and 10 ng/mL lipopolysaccharide (LPS) for M1 differentiation for 48 h. After isolation cells were maintained in RPMI media supplemented with 10% fetal bovine serum and 1% pyruvate. Cytokines were obtained from PeproTech (USA), LPS (from Pseudomonas aeruginosa) was from Sigma-Aldrich (USA). For lactate measurements, macrophages maintained in culture for 6 to 7 days were incubated for 24 h with 7x10 10 PFU Ad Laconic and imaged 6-7 days later.
METHODS

Standard
Imaging
Cells were imaged at 35 o C in a 95% air/5% CO 2 -gassed KRH-bicarbonate buffer of the following composition (in mM): 112 NaCl, 3mM KCl, 1.25 CaCl 2 , 1.25 MgSO 4 , 10 HEPES, 24 NaHCO 3 , pH 7.4. Alternatively, NaHCO 3 was equimolarly replaced with NaCl. Glucose, lactate, pyruvate and inhibitors were added as indicated in the figure legends. Laconic and Pyronic were imaged using an upright Olympus FV1000 confocal microscope equipped a 20X water immersion objective (NA 1.0). Laconic and Pyronic were imaged at 440 nm excitation/480 ± 15 nm (mTFP) and 550 ± 15 (Venus) emissions. BCECF was ester-loaded at 0.1 µM for 3-4 min and the signal was calibrated by exposing the cultures to solutions of different pH after permeabilizing the cells with 10 µg/ml nigericin and 20 µg/ml gramicidin in an intracellular buffer. BCECF was sequentially excited at 440 and 490 nm (0.05 s) and imaged at 535/30 nm using an Olympus BX51 microscope (20X water immersion objective, NA 0.95) equipped with a CAIRN monochromator and Optosplit II (Faversham, UK) and a Hamamatsu Rollera camera.
Immunodetection
For immunoblotting cultured cells were scraped into cold phosphate-buffered saline (PBS 1X) followed by centrifugation at 5,000 rpm for 5 min at 4°C. The cell pellet was then suspended in cold RIPA 1X (radioimmune precipitation assay) lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P40, 10 mM N-ethylmaleimide, 0.1 mM phenylmethylsulphonyl fluoride, 1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pestatin A). After 30 min on ice, unlysed cells and nuclei were pelletted at 12,000 rpm for 15 min at 4°C. The protein concentration of the supernatant was determined by Bio-Rad Dc Protein Assay using BSA standards. Protein samples (50 µg) were loaded onto 10% (w/v) SDS-polyacrylamide gels and electrotransferred onto nitrocelulose membranes. Antibodies used were rabbit anti-MCT4 (1:250; AB3314P, Merck Millipore), mouse anti-β-actin (1:2,000; 8H10D10, Cell Signaling), peroxidaseconjugated antirabbit (1:20,000; 111-035-144, Jackson) and peroxidase-conjugated antimouse (1:20,000; #7076, Cell Signaling). Signals were revealed using a chemiluminescence kit (SuperSignal™ West Femto, ThermoFisher), following the instructions of the manufacturer. For immunocytochemistry macrophages fixed with 4% paraformaldehyde and permeabilized with 0.1% PBS-Triton X-100 were blocked with 3% Bovine Serum Albumin (BSA) plus 10% Normal Goat Serum (Vector Laboratories). Samples were probed with a primary antibody against MCT4 (1:1000; AB3314P, Merck Millipore and AlexaFluor488 secondary antibody (1:2000; A11008, Invitrogen). Nuclei were stained with 4,6-diamidino-2-phenylindole (1:50,000; D3571, Invitrogen). Samples were embedded into fluorescence mounting medium (Dako) and analyzed by confocal microscopy (Leica DMi8, Leica Microsystems) using a 63x oil objective. Image analysis was performed using Leica and ImageJ software.
Mathematical modeling
Cellular lactate and pyruvate dynamics were simulated using Berkeley Madonna software and the following set of ordinary differential equations,
(Eq. 7) dTHP out /dt = K on *TH out *P out + f 2 *TH in -K off P*THP out -f 2 *THP out (Eq. 8) dTHP in /dt = K on *TH in *P in + f 2 *THP out -K off P*THP in -f 2 *THP in (Eq. 9) dL in /dt = LDH forward *P in + K off L*THL in -LDH reverse *L in -K on *TH in *L in (Eq. 10) dP in /dt = Glycolysis + LDH reverse *L in + K off P*THP in -K on *TH in *P in -LDH forward *P in -Mito*P in where equations 1 to 8 represent the eight possible conformations of the MCT carrier: outwardand inward-facing, either empty (T out and T in ), loaded with a proton (TH out and TH in ), loaded with both proton and lactate (THL out and THL in ) and loaded with both proton and pyruvate (THP out and THP in ). Equations 9 and 10 represent cytosolic lactate and pyruvate. 
Statistical Analysis
Statistical analyses were carried out with SigmaPlot software (Jandel). For normally distributed variables, differences were assessed with the Student´s t-test (pairs) and with ANOVA followed by the Tukey-Kramer ad hoc test (groups). For variables that failed the normality test, differences were assessed with the Kruskal-Wallis one way ANOVA on ranks (groups). *, p < 0.05; ns (nonsignificant), p > 0.05. The number of experiments and cells is detailed in each figure legend.
RESULTS
MCT4 mediates monocarboxylate transport in MDA-MB-231 cells
To study the functional properties of MCT4, we expressed the genetically-encoded FRET lactate sensor Laconic 18 in MDA-MB-231 cells, a human breast cancer cell line conspicuous for its high levels of MCT4 28, 29 . Fig. 1A shows MDA-LAC, a cell line generated with MDA-MB-231 cells stably expressing Laconic. Fig. 1B shows that the abundance of MCT4 in these cells is almost as high as that achieved by overexpressing MCT4 in HEK293 cells under the strong CMV promoter, and that MCT4 levels are not diminished by expression of the FRET sensor. Exposure of MDA-MB-231 cells to a lactate load caused a rapid increase in intracellular lactate, demonstrative of high permeability (Fig. 1C) . The functionality of MCT4 was tested by pharmacological means. As there are no commercially available inhibitors specific for MCT4, we tested compounds of overlapping selectivity. pCMBS, which inhibits MCT1 and MCT4 but not MCT2 30 , caused lactate accumulation (Fig. 1C) . In contrast AR-C155858 31 , which blocks MCT1 and MCT2 but not MCT4, had no effect (Fig. 1D) . Taken together, these results show that the tonic export of lactate by MDA-MB-231 cells is mediated by MCT4. The insensitivity to AR-C155858 is in agreement with the reported absence of detectable MCT1 expression in these cells 28, 29 . Next, the effect of the pharmacological inhibitors was tested on lactate uptake. Consistent with the efflux data, pCMBS blocked the uptake of lactate while AR-C155858 did not ( Figs. 2A-B) . Moreover, diclofenac, a structurallyunrelated MCT1 & MCT4 blocker 32 , also abrogated the influx of lactate whereas AZD3965 33 , a structurally-unrelated blocker of MCT1 & MCT2 (but not of MCT4), had no effect (Figs. 2C-D) . These results provide functional confirmation that MCT4 is responsible for the bidirectional transport of lactate across the plasma membrane of MDA-MB-231 cells.
MCT4 of MDA-MB-231 cells is a high affinity lactate/pyruvate transporter
The affinity of MCT4 for lactate was determined by exposing MDA-MB-231 cells expressing the FRET lactate sensor to an increasing extracellular concentration of lactate, as described previously in MCT1-expressing cardiomyocytes 20 . Control uptakes were included at the beginning and end of the protocol to ensure that measurements were reproducible (data not shown). As illustrated in Fig. 3A , robust lactate uptake was already apparent at low lactate concentrations. Plotting uptake rates against lactate concentration revealed K m values in the low milimolar range (Fig. 3B) . To investigate possible confounding effects of experimental conditions, the protocol was repeated in the presence and absence of bicarbonate, at 23 o C and at 35 o C, and in the absence and presence of AR-C155858 (to eliminate possible minor contributions of MCT1 and MCT2), in cells in which Laconic was expressed by transfection, an adenoviral vector, or in a stable cell line. As no strong differences under these experimental conditions were detected, the data were pooled together. The median K m for the uptake of lactate was 1.7 mM. In view of this inordinate high affinity for lactate, an analogous experimental approach was applied to characterize the transport of pyruvate, using the FRET sensor Pyronic
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. Reportedly, the affinity of MCT4 for pyruvate is so low that it lies beyond the measurable range (> 150 mM 34 ). However, we obtained a median K m of 4.2 mM (Fig. 4) . Thus, the affinity of MCT4 for lactate and pyruvate in MDA-MB-231 cells was found to be over one order of magnitude higher than anticipated.
Bicarbonate interferes with pH estimation of MCT4 activity
To evaluate MCT4 activity from its effects on intracellular pH, MDA-MB-231 cells were loaded with the pH-sensitive dye BCECF. Exposure to lactate did acidify the cells, but in contrast with the accumulation of lactate measured directly with the FRET sensor, the acidification was highly sensitive to bicarbonate (Fig. 5A) . In bicarbonate, the rate of acidification induced by lactate did not show saturation. On the contrary, it jumped by a factor of 8 between lactate exposure of 10 and 20 mM. This non-linear behavior suggests that at 20 mM lactate the flux via MCT4 surpassed the capacity of the cells to muffle protons (Fig. 5B) . When bicarbonate was replaced with the impermeant buffer HEPES (no HCO 3 ), intracellular pH became more sensitive to lactate challenges and some degree of saturation appeared (Fig. 5A-B) . A median K m of 27 mM (26 cells three experiments) could be estimated, which is not deemed accurate as it lies beyond the highest lactate concentration applied. Still, this high K m is in agreement with previous determinations of MCT4 lactate affinity in several cell types using pH, which range from 30 to 40 mM 34, 35 . When BCECF-loaded MDA-MB-231 cell were challenged with pyruvate the results were similar: insensitivity in the presence of bicarbonate and responses being detected in the absence of bicarbonate only at > 5 mM pyruvate (Fig. 5B) . There was no apparent saturation of the rate of acidification with or without bicarbonate, so that K m values could not be estimated, as reported 34, 35 . Of note, bicarbonate omission should not be expected to eliminate the problem of buffering, because bicarbonate represents a minor fraction of the buffering power of mammalian cells 36, 37 . In addition to buffering, mammalian cells possess efficient systems for the extrusion of protons, including carbonic anhydrase, Na + /H + exchangers and Na + /bicarbonate cotransporters, some of which have recently been found strategically located in the vicinity of MCTs 38 . We conclude that buffering/muffling reduces the impact of MCT4-mediated proton transport on intracellular pH, particularly at low substrate concentrations, introducing a bias in the determination of affinity.
Recombinant MCT4 is also a high affinity lactate transporter
To explore the functional properties of recombinant MCT4, we used HEK293 cells. They possess abundant MCT1 18 but it is still possible to use them to characterize a foreign transporter if the endogenous MCT1 is blocked pharmacologically, as recently demonstrated for the identification of a Drosophila melanogaster monocarboxylate carrier 25 . As expected, the uptake of lactate by wild type HEK293 cells was blocked by AR-C155858 (Fig. 6A) . Beyond our expectations, overexpression of MCT4 rendered the cells insensitive to the MCT1/2 blocker (Fig. 6B) . We do not know how MCT4 overexpression suppressed the functionality of native MCT1 to such an extent, a phenomenon that may be of physiological interest, as MCT1 and MCT4 may co-exist in the same cells and use the same chaperone basigin/CD147 to reach the plasma membrane 30 . A dominant role for MCT4 was confirmed by full inhibition of lactate uptake by diclofenac (Fig. 6B) . Still, transport affinity was determined in the presence of AR-C155858 to ensure lack of MCT1 & MCT2 function. We found that HEK293-MCT4 cells transport lactate with a median K m of 0.7 mM (Figs.  6C-E) . Thus, high substrate affinity is also a property of recombinant MCT4.
High affinity MCT4-mediated lactate transport in human macrophages
The Warburg effect is important for the activation and operation of macrophages 39, 40 , cells characterized by high MCT4 expression (Fig. 7A ) [41] [42] [43] . To study the affinity of MCT4 in these cells, monocytes were isolated from blood samples collected from healthy donors, transformed into macrophages in vitro and transduced with an adenoviral vector for Laconic. Experiments were carried out with undifferentiated macrophages (M0) and polarized macrophages (M1). In both developmental stages, the uptake of lactate was strongly inhibited by diclofenac but not by AR-C155858, evidencing a preferential role for MCT4 (Fig. 7B) . K m values were similar for M0 and M1 macrophages (Fig. 7C) , with a pooled average of 1.2 mM.
MCT4 but not MCT1 or MCT2 can export lactate against high ambient lactate
The impact of MCT isoforms on cellular lactate and pyruvate dynamics was gauged using numerical simulation based on the alternating conformer model of the transporter (Fig. 8A ) 34, 44 . The behaviors of MCT4 and MCT1 were first compared at physiological levels of lactate and pyruvate (Fig. 8B, left panel) . Glycolytic cells were simulated by tuning mitochondrial pyruvate consumption and transporter dosage so that lactate was exported at 95% of the glycolytic flux 5, 45 . For both isoforms there was pyruvate uptake. It seems remarkable that MCT4 imports almost as much pyruvate as MCT1, despite having an affinity eight times lower. This can be explained by a higher availability of the outward-facing carrier (T IN in Fig. 8A ), pushed by lactate on its way out. This pyruvate uptake helps to replenish the intracellular pyruvate pool and thus sustain lactate efflux, which otherwise would be capped at 90% of the glycolytic flux. The steady-state concentration of lactate and pyruvate were slightly higher in MCT1 cells, but on the whole both isoforms behaved similarly when simulated at low extracellular lactate (Fig. 8B, left panel) .
At elevated ambient lactate, such as is observed within tumors and inflammatory sites, a marked functional divergence between MCT4 and MCT1 became evident (Fig. 8B, right panel) . Here MCT1-bearing cells became pyruvate producers while MCT4 cells maintained their lactate producing role and generated little pyruvate. The divergence was more marked at higher lactate levels (Fig. 8C) and at higher transporter dosages (Fig. 8D) . With mitochondria unable to consume pyruvate, as would occur during in hypoxia, MCT1 cells reverted from lactate producers to consumers at 3.5 mM extracellular lactate whereas MCT4 cells reverted at 13 mM lactate (Fig. 8E) . MCT2-bearing cells showed a strong tendency towards lactate consumption (Fig. 8D-F) consistent with the expression of this isoform in highly oxidative cells like neurons 46 . For simplicity, the cellular NADH/NAD + ratio in these simulations was fixed, that is, it was implicitly assumed that mitochondria compensate for deficits in NAD + recycling at LDH. If this were the case, MCT4 cells will not only release more lactate than MCT1 cells will use less oxygen. Lactate and pyruvate fluxes are not only determined by MCTs, but also by glycolytic and mitochondrial fluxes and the redox ratio. Thus, these simulations do not cover every possible condition, but serve to demonstrate that all things being equal, MCT4 is more suited for lactate export than MCT1 and MCT2 at high ambient lactate levels.
DISCUSSION
Our main conclusion is that MCT4 is a high affinity lactate transporter and that has a relevant affinity for pyruvate. A similar K m for lactate of around 1 mM was determined in three different cell types including endogenous and recombinant MCT4, which suggests that this is a general property of the isoform. High affinity for lactate and a somewhat lower affinity for pyruvate confer MCT4-expressing cells the ability to export lactate against high ambient lactate levels, a role that is not possible for either MCT1 or MCT2, which cannot help losing pyruvate. This ability helps to explain why MCT4 is preferentially expressed in metastatic tumors, rapidly proliferating cells and hypoxic tissues.
How come MCT4 has been considered to be a low affinity lactate transporter with negligible affinity for pyruvate? When BCECF was first used to monitor monocarboxylate transport in 1990, bicarbonate was purposely omitted from experimental solutions "to minimize intracellular buffering in order to produce greater and faster pHi changes when small amounts of lactate were introduced"
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. Shortly afterwards, BCECF was used to estimate kinetic parameters, also in bicarbonate-free conditions 17 . We confirm here that bicarbonate makes a big difference in the acidification induced by lactate. However, bicarbonate omission is not enough to eliminate the problem of buffering, because bicarbonate represents only a 30-50% of the buffering power of mammalian cells, the remainder being shared by protonable aminoacid residues, phospholipids, metabolites, etc 36, 37 . As well as buffering, mammalian cells possess efficient systems for the extrusion of protons, including carbonic anhydrase, Na + /H + exchangers and Na + /bicarbonate cotransporters, some of which are strategically located in the vicinity of MCTs
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. Of note, NBCe1 remains active even in the nominal absence of bicarbonate 47 . A study in Xenopus laevis oocytes showed that the MCT4 activity is enhanced by membrane-anchored carbonic anhydrase. Significantly for affinity estimations, the effect of carbonic anhydrase was stronger at low lactate concentrations 48 . Our interpretation of the bias introduced by pH measurements is that on the whole, the pH regulatory system is saturable. Challenged by low lactate loads, it copes well so that intracellular pH remains stable in spite of lactate influx. At higher lactate loads, the regulatory system is overwhelmed and cells acidify. In the presence of bicarbonate, pH regulation is even stronger, so that MCT-mediated pH changes are difficult to detect even at high lactate loads, and particularly in response to pyruvate, which is a less efficient substrate. The confounding effect of pH regulation leads to a biased estimation of affinity. Whereas proton buffering and muffling explain the high apparent K m values previously reported for MCT4 in mammalian cells, it is not clear to us why a study based on radiolabeled lactate also reported a high K m in MCT4-expressing oocytes (34 mM 14 ). The affinity measured here in HEK293-MCT4 cells suggest that overexpression may not account for the discrepancy, neither would genetic variability, because the splice variants of MCT4 do not include the protein coding region 34 . Perhaps factors present in mammalian cells but not in Xenopus oocytes endow MCT4 with high affinity? Prime candidates are carbonic anhydrase and proton extrusion mechanisms, which when co-expressed in oocytes enhance the uptake of lactate 38, 48 . Alternatively, the estimation of K m in millimeter-sized oocytes may have been affected by unstirred layers that are not present in micrometer-sized mammalian cells, as discussed previously 13 . A non-exclusive possibility is metabolism. The radiolabeled assay involved incubation for 20 minutes, during which some lactate may have been metabolized, an effect that would be more evident at low lactate loads. Xenopus laevis oocytes have a strong oxidative phosphorylation relative to glycolysis, producing CO 2 from pyruvate 80-140 times faster than from glucose 49 . They also have endogenous MCT and LDH 50, 51 , and are therefore equipped to metabolize lactate. In the case of mammalian cells, oxidative phosphorylation is much slower than MCT-mediated transport, so it should not interfere significantly with the uptake assay. Still, a sizable metabolic interference in mammalian cells, a possibility that we do not favor, would mean that the affinity of MCT4 for its substrates is even higher than reported here. It has been proposed that MCT4 has a higher transport capacity than MCT1 14 . Calibrated lactate and pyruvate measurements accompanied by parallel measurement of MCT surface expression are needed to address the pending question of transport capacity.
MCT4 versus MCT1 and MCT2
The most widely expressed, house-keeping member of the monocarboxylate transporter family is MCT1. It has an affinity for pyruvate 5-10 times higher than that for lactate, commensurate with the ratio between the physiological concentrations of the two substrates. MCT1 plays a major role in whole-body energy homeostasis and in the distribution of redox potential between organs 52 . It is also widely expressed in tumors, where it mediates both the export and import of lactate 12, 53 .
Hypoxic cells may only use glycolysis to generate ATP, and to sustain glycolysis they need to recycle the NADH produced at GAPDH. With oxidative phosphorylation disabled in the absence of oxygen, NADH may only be recycled at LDH, the enzyme that converts pyruvate into lactate. Thus, to generate energy, hypoxic cells need to release lactate but not pyruvate, a task that is fitting for MCT4, but not for MCT1. This helps to explain why only the expression of the MCT4 is under the control of HIF-1α 11 . At variance with hypoxic cells, which require glycolytic ATP production for survival, cancer cells are capable of generating their ATP in mitochondria by oxidative phosphorylation 45 . For reasons that are not fully understood, but which include the interstitial effects of lactate and protons 5 , some cancer cells engage in a glycolytic frenzy to export almost every glycolytic carbon in the form of lactate [1] [2] [3] [4] . They do this against elevated ambient lactate levels caused by inflammation, hypoxia and/or the Warburg effect in neighboring cancer and stroma cells [4] [5] [6] 9 . According to our numerical simulations MCT1 cells may only produce lactate at low ambient lactate levels, because at high lactate levels they cannot avoid producing pyruvate. Consistently, pharmacological MCT1 inhibition in breast cancer cells was found to inhibit the release of pyruvate but not that of lactate 54 . In contrast, MCT4 exports lactate regardless of extracellular lactate levels.
As well as to contributing to the understanding of high-lactate microenvironments, the revised kinetic properties we report here may inform the development of urgently-needed specific MCT4 blockers.
